We added the following clinical trials for triple-negative, HER2-positive, and other subtypes of metastatic (stage IV) breast cancer to Metastatic Trial Search last month.
Stage IV Triple Negative Breast Cancer
- Trilaciclib and Sacituzumab Govitecan for Advanced Triple Negative Breast Cancer
- RAPA-201 Immunotherapy for Advanced Triple Negative Breast Cancer
- How the Gut Microbiome May Affect Immunotherapy in Stage I-IV Triple Negative Breast Cancer
Stage IV HER2-Positive Trials
Stage IV HR Positive Trials
Other Stage IV Trials
Last Modified on January 12, 2022